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ABSTRACT We analyze a model for the reversible cross-linking of cell surface receptors by a collection of bivalent ligands
with different affinities for the receptor as would be found in a polyclonal anti-receptor serum. We assume that the amount
of cross-linking determines, via a monotonic function, the rate at which cells become activated and divide. In addition to the
density of receptors on the cell surface, two quantities, the binding field and the cross-linking field, are needed to characterize
the cross-linking curve, i.e., the equilibrium concentration of cross-linked receptors plotted as a function of the total ligand
site concentration. The binding field is the sum of all ligand site concentrations weighted by their respective binding affinities,
and the cross-linking field is the sum of all ligand site concentrations weighted by the product of their respective binding and
cross-linking affinity and the total receptor density. Assuming that the cross-linking affinity decreases if the binding affinity
decreases, we find that the height of the cross-linking curve decreases, its width narrows, and its center shifts to higher ligand
site concentrations as the affinities decrease. Moreover, when we consider cross-linking-induced proliferation, we find that
there is a minimum cross-linking affinity that must be surpassed before a clone can expand. We also show that under many
circumstances a polyclonal antiserum would be more likely than a monoclonal antibody to lead to cross-linking-induced
proliferation.
INTRODUCTION
Frequently, cellular responses, such as antigen-induced pro-
liferation of B cells or histamine release from basophils,
exhibit dose-response relationships that are bell-shaped
when the amplitude of the response is plotted against the
logarithm of the antigen concentration (e.g., Celada, 1971;
Dintzis et al., 1976; Metzger, 1992). It has been shown
(DeLisi and Perelson, 1976; Dembo and Goldstein, 1978;
Perelson and DeLisi, 1980) that such log bell-shaped dose-
response functions result when the response depends upon
the fraction of receptors cross-linked on the cell surface.
(Other mechanisms can also give rise to phenomenological
log bell-shaped dose-response functions (cf. Sulzer et al.,
1993).) At low ligand concentration there is little binding
and hence little cross-linking. At high ligand concentration
almost every receptor site is occupied by a singly bound
ligand, preventing the formation of cross-links. Therefore,
cross-links are formed efficiently only at intermediate li-
gand concentrations. Clearly, the ligand has to be at least
bivalent to be capable of forming cross-links.
Models of the B cell response induced by antigen or
anti-immunoglobulin (anti-Ig) as a triggering signal have
commonly employed log bell-shaped functions to describe
the dose dependence of the B cell response (De Boer, 1988;
Varela et al., 1988; Weisbuch et al., 1990; De Boer et al.,
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1992; Sulzer et al., 1993). In all of these models, dose-
response functions have depended upon a single variable,
usually called the field. The field is defined as a linear
superposition of the concentration of all ligands weighted
by interaction constants that are often identified with the
affinity of the corresponding ligand for its receptor.
Phenomenological dose-response relationships defined
by these one-parameter functions describe correctly the
overall shape of the dose dependence of the cellular re-
sponse. However, they do not capture essential properties of
the dose dependence of the concentration of cross-links, i.e.,
of cross-linking curves. For example, the cross-linking
curves generated by ligand-receptor pairs with the same
affinity but with different equilibrium constants for cross-
linking have different widths and heights (Dembo and
Goldstein, 1978; Perelson and DeLisi, 1980). However, the
commonly used one-parameter dose-response functions, by
design, always have the same width and height. Thus in
situations where cross-linking underlies the biological re-
sponse, it would be desirable to utilize dose-response func-
tions that more accurately reflect the cross-linking process.
Recently, Faro and Velasco (1993, 1994) have modeled
the formation of cross-links on B cells by multivalent li-
gands. Following Bell (1974), they assume that the forma-
tion of cross-links is an irreversible process, and they mea-
sure the rate of B cell activation by the characteristic time it
takes to form infinite-size ligand-receptor aggregates (in a
system of infinite size). The shorter the time to achieve
infinite clusters the larger the rate of cell activation. They
argue that a one-parameter response function does not de-
scribe correctly the rate of formation of cross-links. Below,
we also argue that one-parameter dose-response functions
are not appropriate. However, we do so for different reasons
1154
Binding and Cross-Linking by Bivalent Ligands
because there is no evidence that infinite-size or even very
large aggregates are needed to trigger a cell. For example,
experiments by Dintzis et al. (1976) suggest that aggregates
of about ten should suffice.
We consider bivalent ligands, such as anti-Ig or two
dinitrophenyl (DNP) groups separated by a small spacer, for
which cross-linking is well described as a reversible chem-
ical process (cf. Dembo and Goldstein, 1978; Dembo et al.,
1978; Dower et al., 1984). For many bivalent ligands,
binding and receptor aggregation reactions are fast com-
pared to the kinetics of the cellular response (Dembo and
Goldstein, 1978; Goldstein, 1988). This suggest that for
such ligands the rate of cellular response may be a function
of the equilibrium distribution of cross-linked receptors.
Whereas cross-linking of receptors by a single bivalent
ligand has been thoroughly studied (DeLisi and Perelson,
1976; Dembo and Goldstein, 1978; Dembo et al., 1978;
Reynolds, 1979; Perelson and DeLisi, 1980; Perelson et al.,
1980; Perelson, 1984; Macken and Perelson, 1985; Wofsy
and Goldstein, 1987; Posner et al., 1995), little has been
done to analyze situations where collections of bivalent
ligands compete for binding to receptors, even though this is
surely the case when cells interact with polyclonal rather
than monoclonal anti-receptor antibody.
Based on the binding model presented below we con-
clude that a polyclonal antibody serum may give rise to a
significantly greater amount of cross-linking than a mono-
clonal antibody (cf. Fig. 1), although the average affinity of
the serum and the affinity of the monoclonal antibody are
the same. Prerequisite for this greater efficiency in forming
cross-links is that the equilibrium constant for cross-linking,
i.e., the cross-linking affinity, increases when the corre-
sponding equilibrium constant for binding from solution,
i.e., the binding affinity, increases. Fig. 1 shows that in this
case the overwhelming majority of cross-links (more than
96%) is formed by the high-affinity component of the serum
(black portion in P1). A significantly smaller fraction of
cross-links (73%) are constituted by the high-affinity com-
ponent when the cross-linking affinity is identical for all
antibodies in the serum (black portion in P0). In this case,
we find no increase in the amount of cross-linking over the
corresponding monoclonal antibody (M and P0 have the
same height in Fig. 1). We return to the comparison of
polyclonal and monoclonal antibody preparations under Ef-
ficiency of Monoclonal and Polyclonal Stimuli. Because the
equilibrium binding properties of collections of ligands
depend on how the cross-linking affinity changes with the
binding affinity (as illustrated by the example), we devote a
major part of our paper to the exploration of the conse-
quences of different relationships between binding affinity
and cross-linking affinity.
In the next section we derive the equilibrium concentra-
tion of cross-links, the crosslinking curve, for collections of
ligands and receptors with different affinities. As we discuss
further under Excess Ligand Regime, two quantities, the
binding field and the cross-linking field, are necessary and
sufflcient to characterize the cross-linking curve of bivalent
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FIGURE I Cross-linking induced by three different kinds of serum. M
denotes a monoclonal antibody of binding affinity K = 106 M'- and
nondimensional cross-linking affinity KXRT = 1 (see Ligands of Different
Affinities Cross-linking Receptors on Different Cell Clones for notation).
P0 and P1 are polyclonal sera, both composed of 70% low-affinity anti-
body Ab, (KI = 105 M -), 23% medium-affinity antibody Ab2 (K2 = 106
M- 1), and 7% high-affinity antibody Ab3 (K3 = 107 M-'). All antibodies
in P0 have the same nondimensional cross-linking affinity KX jRT = 1, i =
1, 2, 3. In serum P1 the nondimensional cross-linking affinity increases in
proportion to the binding affinity, i.e., KX IRT = 0.1, KX,2RT = 1, and
Kx 3RT = 10. Thus, all preparations have identical average binding affinity
and average cross-linking affinity. Shading of the bars shows how many
cross-links are formed by Ab, (white), Ab2 (gray), and Ab3 (black).
Comparing P0 and P1, we observe a pronounced enhancement of the
number of cross-links formed by the high-affinity antibody Ab3 in the
polyclonal serum P1, yielding a much greater total number of cross-links.
Thus the polyclonal serum P1 is more effective in cross-linking than
the monoclonal antibody M. Data are taken at a total ligand concentration
of 10-6 M.
ligands. This means that even for collections of arbitrarily
many bivalent ligands a function of only two variables
suffices to capture all essential features of cross-linking
curves. We study the situation in which the cellular response
is a monotonically increasing function of the amount of
receptor cross-linking under Cellular Response. We show
that clones with low cross-linking affinity are essentially
nonresponsive (Response Curves of Cells with Different
Affinity), a feature that has been missed in models that used
a one-parameter phenomenological dose-response function.
Using our theory we also explain why polyclonal anti-
receptor antiserum can be more effective in stimulating a
biological response than monoclonal antiserum under Effi-
ciency of Monoclonal and Polyclonal Stimuli.
LIGANDS OF DIFFERENT AFFINITIES
CROSS-LINKING RECEPTORS ON
DIFFERENT CELL CLONES
To introduce our model let us first consider the binding of
one type of bivalent ligand to a single kind of cell surface
receptor. Binding of free ligand, at concentration C, to a free
receptor site, at concentration F, yields singly bound ligand,
Cl. Doubly bound ligand, C2, is formed when the second
site on a singly bound ligand binds a free receptor site. We
measure the concentration of free ligand in mol/liter M
and the cell surface concentrations, F, C1, and C2, in units
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of 1/cm2. The following mass-action rate equations describe
the kinetics of ligand binding and cross-linking receptors
(see Fig. 2; compare DeLisi and Perelson, 1976; Perelson
and DeLisi, 1980):
C1 = 2k+FC - k C1 + 2k-C2 - k+FC1 (1)
C2 = k+FC1 -2k-C2. (2)
The initial binding of unbound ligand to a free receptor site
is governed by the forward rate constant k+ and the reverse
rate constant k-, which are measured per site. We define the
corresponding binding affinity by K k+lk-. The second
binding step on the cell surface leading to cross-links de-
pends on the forward cross-linking rate constant k+ and the
reverse cross-linking rate constant kx with the associated
cross-linking affinity Kx k+,/§kx. We measure k+ in
M- '/s, k+ in cm2/s, and the reverse rate constants k- and kx
in 1/s. Accordingly, the unit of the binding affinity K is M- 1
and that of the cross-linking affinity KX is cm2. There are
two free sites on the ligand, and either can bind to a free
receptor site; thus a factor of 2 appears in the first term in
Eq. 1. Similarly, a doubly bound ligand can dissociate from
either of two sites, and hence kj is multiplied by 2.
Conservation of receptor sites and ligand requires
RT=F+Cl +2C2,
CT= C + aBC, + aBC2,
(3)
(4)
where CT is the total ligand concentration and RT the total
receptor site concentration. In Eq. 4 the cell surface con-
centrations of bound ligand C1 and C2 have to be multiplied
by the cell concentration B and a scale factor a to render
them compatible with the volume concentrations CT and C
(cf. Sulzer and Perelson, manuscript submitted for publica-
tion). For the units of measurement specified above, a is the
ratio of the mean cell surface area and Avogadro's number
times 103. Assuming that small B cells are spherical cells
with a radius of 3.5 ,um (Strand, 1978), i.e., a surface area
of 1.5 X 10-6 cm2, we obtain a 2.5 X 10-27 cm2 mol.
A typical value for the total receptor concentration is RT =
6.7 X 1010 cm-2, corresponding to 105 antibody sites per B
cell (Paul, 1993).
Implicit in this formulation is the assumption that a cell
carries one and only one specificity of receptor that binds
the ligands at hand, and that if the receptor has multiple
sites that they bind ligand independently and with the
same rate constants (this latter feature is called the equiv-
alent site hypothesis). The assumption of a single recep-
tor specificity is valid for the binding of antigens to
immunoglobulin on B cells. (We use the term "specific-
ity" here because B cells have receptors with different
constant regions, e.g., IgD and IgM, but with the same
variable region and hence the same binding specificity.)
When a multivalent ligand binds to a bivalent or multi-
valent receptor, ligand-receptor aggregates can form that
may contain rings (Perelson and DeLisi, 1980; Posner
et al., 1995). Here we neglect ring formation. Thus the
theory developed here is rigorous for monovalent receptors,
such as Fc receptors, but is only an approximation for multi-
valent receptors for which ring formation can occur.
Before we generalize Eqs. 1 through 4 to capture the
binding between collections of different ligands and cell
clones, we switch to new variables, which prove to be
more convenient for our purpose. For a bivalent ligand
composed of two identical haptens separated by a spacer,
concentrations can be expressed in terms of the hapten
concentration or in terms of the ligand concentration.
Because binding would typically be via the haptens, we de-
velop our theory here in terms of hapten concentration or more
generally ligand binding site concentrations. Thus, let
L=2C (5)
be the concentration of binding sites on unbound ligand.
Moreover, we express all cell surface concentrations in
terms of the receptor sites involved. This choice seems
appropriate, because the response of the cell depends on the
state of its receptors. We denote the fraction of free receptor
sites by R, the fraction of receptor sites occupied by singly
bound ligand by S, and the fraction of receptor sites occupied
by ligand that has both sites bound by X. Then, the relations
R FIRT S Cu/RT and X 2C2/RT (6)
define the transformation between the new, nondimensional
variables and the cell surface concentrations used in Eqs. 1-4.
We describe the binding of a set of N different bivalent
ligands to the receptors on a set of M different clones of
cells by monitoring Sij, the fraction of receptor sites of type
i occupied by a singly bound ligand of type j, and Xij, the
fraction of receptor sites of type i occupied by a ligand of
type j that has both sites bound. That is, Xij is the fraction of
c
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FIGURE 2 Binding and cross-linking of bivalent receptors by bivalent ligand. Unbound ligand, C, binds to free receptor sites, F, with rate constant k+,
giving rise to singly bound ligand, C,. Cross-linking occurs when the free site of a singly bound ligand binds to a free receptor site with rate constant kx
resulting in doubly bound ligand, C2. Cross-links dissociate with rate constant k-, and singly bound ligand dissociates with rate constant k.
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receptor sites i in crosslinks formed by ligand j. Using Eqs.
5 and 6 in Eqs. 1 and 2 we obtain
Sij = kijRiLj -(k1j + RiRiTkxij)Sij + kX-jjXi7
i= 1, *-,-M; j= 1, ,N,
Xij= 2(RiRiTk+1jSij- (8)
i= 1, --,M; j= 1, --N.
The factor 2 in Eq. 8 is due to the fact that Xij describes the
number of receptor sites in cross-links; formation and dis-
sociation of cross-links affect two receptor sites simulta-
neously. We assume that the total concentration of receptor
sites RiT is constant.
Conservation of receptor and ligand sites, Eqs. 3 and 4,
now reads
N
1 = Ri + I (S1i + Xi), i = 1,* *,fM, (9)
j=1
LjT = Lj + a BRiT(Sij + 2 Xi;) j = 1,9 * *, N,
(10)
where LjT is the total concentration of ligand sites j.
At equilibrium, the fraction of receptor sites occupied by
singly bound ligands and those of receptor sites in cross-
links are given by
SXj = RiKijLj, i = 1, * * M; j = 1 N, * * *,N (21)
Xj = RiRiTKx,ijSij, i= 1,*,---M; j= 1,---,9N. (12)
Using Eqs. 11 and 12, the conservation equation for recep-
tor sites at equilibrium becomes
1 = R2hx + Ri(hj + 1), i = 1, ** *, M, (13)
where we have defined the cross-linking field, hx1, and the
binding field, hi, by
N
hx,= E RiTKx,ijKijLj, j= l,- - ,M, (14)
j=1
N
hi-E KijLj,
j=l
i=1,***,M.
We emphasize that these two ligand-dependent quantities
are necessary to describe the cross-linking of receptors by a
collection of bivalent ligands of different affinities and the
ensuing cellular response properly. Models of the B cell
response frequently refer to cross-linking as a possible
explanation for the bell-shaped dose-response curve they
assume (De Boer, 1988; Varela et al., 1988; Weisbuch et al.,
1990; De Boer et al., 1992; Sulzer et al., 1993). However,
they have not taken into account that two parameters are
required and have, instead, used dose-response functions
that depend upon a single parameter that is equivalent to the
binding field, hi, in Eq. 15.
The equilibrium concentrations of free ligand sites, which
are needed to specify the fields (Eqs. 14 and 15), are given by
L- 1 LjT
i + alkM=l BkRkRkTKkj (I + 1/21kRkTKx,kj) (16)
an expression derived by inserting Eqs. 11 and 12 into the
conservation equation for ligands (Eq. 10).
Formally, the conservation equation for receptor sites,
Eq. 13, looks similar to the conservation equation used in
the case of binding of a single ligand type to a single
receptor type (Perelson and DeLisi, 1980). In general, how-
ever, the conservation equations for different clones of cells
expressing receptors with different affinities are coupled,
because the free ligand site concentrations that occur in the
fields (Eqs. 14 and 15) depend on all of the free receptor site
concentrations. In the next section we show that the con-
servation equations for receptor sites (Eq. 13) decouple in
the excess ligand approximation, where we assume Lj =
LjT, and we recover a generalized form of the results of
Perelson and DeLisi (1980). The excess ligand approxima-
tion is valid when the ligand site concentration is much
larger than the receptor site concentration.
EXCESS LIGAND REGIME
Biologically, we frequently encounter situations where the
ligand site concentration is much larger than the corre-
sponding receptor site concentration. Under such circum-
stances, ligand binding hardly affects the concentration of
free ligand sites, and one can assume Li = LiT. This we call
the excess ligand approximation. At the initiation of an
immune response, for instance, the antigen concentration
usually exceeds the concentration of membrane-bound im-
munoglobulin on the few antigen-specific B cells by orders
of magnitude. Only late in the response, when the specific B
cell populations have expanded considerably and antigen is
almost eliminated, is the excess ligand approximation ex-
pected to fail. In vitro experiments have been set up so that
the excess ligand approximation is valid (e.g., Dembo et al.,
1978). Thus, it is worthwhile to examine the excess ligand
regime in detail. The analysis in the remainder of this paper
is performed under the assumption of the excess ligand
regime.
We use the excess ligand approximation when the sec-
ond, cell-concentration-dependent term in the denominator
of the equilibrium concentration of free ligand sites (Eq. 16)
is much less than 1, i.e.,
a I BkRkRkTKkj+ 21 RkkTKxkj) «1.
k=l
(17)
Then the concentration of free ligand sites hardly differs
from the total concentration of ligand sites, because the tiny
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amount of binding to a few receptors hardly affects the vast
pool of unbound ligand.
The excess ligand approximation is exact when the cell
densities Bi vanish. Here, the free ligand site concentration
becomes identical to the total ligand site concentration (cf.
Eq. 16). The conservation equations for receptor sites (Eq.
13) decouple, because the cross-linking and the binding
fields now depend on the constant total ligand site concen-
trations, i.e.,
N
hx,i = E RiTKX,ijKijLjT,
j=l
and
N
hi = E KijLjT,
(18)
and, thus, the symmetries of X(8) are identical to those of
6(h, hx) itself. Perelson and DeLisi (1980) have shown that
6 has a single maximum at h = 1 irrespective of the value
of hx, or that 6 expressed as a function of the ligand site
concentration L has a maximum at L = K71.
We now generalize these results to the multi-ligand
case. Defining the ligand composition f {fjILT = A L,
j = 1. N}, where LT I LjT. is the total ligand site
concentration (A is the fraction of ligand j in the set of
ligands, {LjT, j = 1, ..., N}), we can rewrite the binding
and cross-linking fields in the form
N
h =2KjjLr (K)Lr,
(19)
and hence are independent of the number of free receptor
sites.
The fraction of free receptor sites on cells of type i can
easily be computed in the excess ligand regime from Eq. 13,
with the fields given by Eqs. 18 and 19:
(24)
and
N
hX = RT E KX jKjfjLr = RT(KXK)Lr (25)
Under the condition that the ligand composition is fixed, we
can write 6 as function of a single variable, the total ligand
site concentration, Lr, i.e.,
-(hi + 1) + (hi + 1)2 + 4hx,i
-'-X,j (20)
i= 1, -,M.
We define (cf. Perelson and DeLisi, 1980)
hX'i
i(hi, hx,j) 3(hi + 1)2 (21)
and obtain from Eqs. 11 and 12
N l+ 2 Si- 1+~46,
X= EXj = R2hi= 2
j=1 (22)
i= .1-M,
for the fraction of receptor sites in cross-links on cells of
type i.
Equations 18 through 20 show that in the excess ligand
regime the binding of ligands to a certain clone of cells does
not affect and is not affected by the binding of ligands to
other cell clones. Because of this mutual independence of
the binding properties for cells carrying different receptors,
we focus on a particular type of cell and drop the index i for
the following considerations in which we derive some fun-
damental properties of the cross-linking curve.
The fraction of receptor sites in cross-links, X, when
plotted against the ligand site concentration, is called a
cross-linking curve. As noted by (Perelson and DeLisi,
1980) in the case of a single ligand, X is a monotonically
increasing function of 8, i.e.,
dX(6) 1 + 26- 1 + 46
d8 262 1+6 >0 (23)
RT(KXK)LF6(Lr) = ((K)Lr + 1)2 (26)
6(Lr) attains its maximum where the total ligand concen-
tration is equal to the inverse of the average binding affinity,
LT = (K) = LrTmax, since
d6 _ RT(KXK)(1- (K)LT)
dL,r ((K)Lr + 1)3 (27)
Moreover, S(LT) as a function of the total ligand site con-
centration for fixed ligand composition f is symmetric on a
logarithmic scale around its maximum at LTma, i.e. (com-
pare Dembo and Goldstein, 1978, as well as Perelson and
DeLisi, 1980, Theorem 2),
af RT(KxK)(ff)-'f RT(KxK)(K)-'f-16(Lq,max ((K)K)-I + 1)2 = ((K)K)' + (-1)2
(28)
RT(KxK)(K)- te
(1 + (K)(K)-1e-I)2 8(L=,maxf )
Equation 28 holds for any value of f, a real number mea-
suring the distance from Lrmax. Only the height of the
maximum depends upon the cross-linking affinity. It is
given by (compare Perelson and DeLisi, 1980, Theorem 3)
Xmax =- X(h = 1, hx)]
=1+ 2(K) RT(
(29)
Summarizing, the bell-shaped nature of the cross-linking
curve and the location of its maximum in the case of a
collection of ligands remain the same as in the single
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ligand-single cell case (Perelson and DeLisi, 1980), when
we generalize the binding affinity to be the average binding
affinity and the ligand site concentration to be the total
ligand site concentration.
CELLULAR RESPONSE
Cross-linking of its receptors may activate a cell and induce
a response such as cell division. In this section we discuss
how to model the cellular response as a function of the
average concentration of receptor sites in cross-links. Our
approach will be phenomenological in that we do not at-
tempt to capture the triggering of intracellular signaling
cascades by cross-linked receptors, which eventually cause
the cell to respond (cf. Cambier and Ransom, 1987;
Cambier et al., 1994).
We consider the proliferative response of B cells to
bivalent antigen. In De Boer et al. (1996) we apply the
theory developed here to idiotypic networks, in which case
the bivalent antigen is an anti-idiotypic antibody binding to
B cell receptors. Ligand-receptor binding reaches equilib-
rium within a few minutes for most antibody-hapten com-
binations. Pecht and Lancet (1977), for instance, show that
in a large sample of antibody-hapten combinations the re-
verse rate constant k- is on the order of 0.1 s-1 or larger
except for a few high-affinity interactions. The inverse of
the reverse rate constant gives a lower bound to the time
scale on which equilibrium is attained. The same is true for
bivalent ligands when we assume that the rate constant
for the dissociation of crosslinks, k7Xj1, is comparable to kij
(Perelson and DeLisi, 1980). In this case, the time to reach
chemical equilibrium is small compared with typical time
scales of the cellular response; a B cell divides at most once
every 6 h (Zhang et al., 1988). Consequently, we assume
that the equilibrium concentration of cross-links on a B cell
is the relevant quantity determining its response.
When binding relaxes to equilibrium on a time scale
comparable to the cellular events one has to consider how
the cross-linking curve changes in time. Qualitatively, the
height and width of the cross-linking curve increase, and it
attains its maximum at progressively lower ligand concen-
tration (Perelson and DeLisi, 1980; Perelson, 1980). The
response rate may then depend on the number of cross-links
that can be established before the occurrence of cellular
events that prevent further receptor-mediated signaling. B
cells, for instance, internalize their antibody receptors
within an hour after binding has started (Pure and Tardelli,
1992).
More dynamical notions of cell activation are conceiv-
able, too. Instead of the concentration of cross-linked re-
ceptors the rate of recruitment of new receptors into the
cross-linked state may be the signaling event on the cell
membrane. If cross-linking is an irreversible process the
average time needed to form a sufficiently large ligand-
receptor cluster may be a better candidate for the signaling
event (Bell, 1974; DeLisi and Perelson, 1976; Faro and
Velasco, 1993, 1994); note that in the case of irreversible
cross-linking all receptors are cross-linked at equilibrium. If
the reverse binding constant is on the order of 10-3 S-1 or
smaller the reaction will attain its equilibrium on the time
scale of hours and a dynamical description of cell activation
will be more appropriate than our equilibrium analysis.
Dynamical notions of receptor ligation and cell activation
are beyond the scope of this paper, however.
Even if receptor cross-linking reaches equilibrium rapidly
compared with a cellular response, we are still confronted
with the question: How does the rate of the cell's response
depend upon the number of cross-links on its surface? In
general, the response may not be exactly proportional to the
fraction of receptor sites in cross-links and may differ
depending on the particular response being modeled, e.g.,
proliferation, antibody secretion, etc. The amount of hista-
mine released by basophils has been shown to depend
monotonically upon the number of cross-links on the cell
surface (Dembo et al., 1978). Goroff et al. (1991) show that
cross-linking of their IgD receptors is necessary for the
activation of B cells and subsequent antibody secretion. In
the absence of a quantitative relationship between the de-
gree of cross-linking and the rate of B cell responses we
assume that, in analogy to basophils, the observed response
is a monotonically increasing function of X, the fraction of
receptor sites cross-linked. A class of functions possessing
this property is the set of sigmoid response functions Fr of
the form
Fr(X)
-Xq + lo,i (30)
which we shall use for our analysis below. In this Hill
function the signaling threshold e¶ determines the number of
cross-links required for half-maximum response. The Hill
coefficient q controls the steepness of the transition from no
to full response. Different types of responses may be char-
acterized by different signaling thresholds and/or Hill coef-
ficients (e.g., Monroe and Cambier, 1983). This fact con-
stitutes one of the tacit assumptions of the model of the B
cell response introduced by Sulzer et al. (1993) where
proliferation and terminal differentiation of B cells may
require a different degree of cross-linking. Consistent with
the notion of different signaling thresholds are the results of
Mongini et al. (1991), which show that cross-linking-in-
duced progression into different phases of the cell cycle has
different affinity requirements. Implicit in this formulation
is the assumption that T cell help is not limiting for the
response under consideration.
Nonmonotonic relationships between the equilibrium
concentration of cross-links and the cellular response are
also observed. The histamine release of basophils, for in-
stance, has been shown to decrease in some patients when
the concentration of cross-links still increases (Becker et al.,
1973; Magro and Alexander, 1974). In many cases, this
nonmonotonic dependence can be explained as the net result
of two antagonistic, elementary reactions with different
Sulzer et al. 1159
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dose-response relationships (cf. Dembo and Goldstein,
1980; Sulzer et al., 1993). Perelson et al. (1982) discuss a
kinetic method for determining whether the decline in his-
tamine release at high ligand concentrations is due to a lack
of cross-links (type I inhibition) or is an example of this
nonmonotonic behavior, i.e., is due to too much cross-
linking (type II inhibition).
For cross-linking-induced B cell responses we expect
signaling thresholds e~between 10-4 and 10- 1 because, on
one hand, at least a few receptors must be cross-linked to
distinguish spontaneous from induced responses (10 bound
receptor sites on a cell with 105 receptor sites yields the
lower estimate; here we assume that a B cell carries about
50,000 antibody receptors) and, on the other hand, aggre-
gation of all receptors cannot be required or else the cell
cannot be sensitive to a reasonable range of stimuli (10%
receptor sites bound yields the upper estimate).
Let us assume that the B cell proliferative response obeys
a dose-response relationship of the type defined by Eq. 30,
where the threshold for proliferation is denoted lp and the
proliferative response function is called Fp. We show the
fraction of receptor sites in cross-links (low dashed curve)
and one-parameter families of dose-response functions (sol-
id lines) for proliferation in Fig. 3. The width of the prolif-
eration function Fp increases as the signaling threshold, Up,
decreases left panel), because the cells require a smaller
number of cross-links to start a response. As the Hill coef-
ficient q increases (right panel) the transition from no
proliferation to maximum proliferation becomes steeper.
Dose-response functions for other kinds of cellular re-
sponses may be expected to depend in the same way upon
the parameters e and q.
Now we are ready to ask how the proliferative response
of B cells depends on the affinities of the antibody-antigen
1.0
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FIGURE 3 Proliferation functions for different response characteristics.
We show the dose-response relationship for proliferation of B cells em-
ploying the phenomenological sigmoid response function, Eq. 30, varying
the parameters iap and q of the response function. The low dashed curve in
both panels displays the cross-linking curve for ligand-receptor interaction
with binding affinity K = 106 M-' and a nondimensional cross-linking
parameter RTKX = 1. In the left panel, &p = 10-1, 10-2, 1O-3, and 10-4
(inside to out) for q = 1. In the right panel, q = 1, 2, 4, and 8 (bottom to
top at the maximum) for i5p = 10-2. The dotted line shows an example of
the ratio of the decay rate to the proliferation rate of B cells: dip = 0.2. A
ligand/antigen is stimulatory at concentrations where Fp is larger than dip
(see Eq. 31). We observe that the range of stimulatory ligand site concen-
trations increases as the signaling threshold Op decreases.
interaction. To address this question we employ a simple
model for B cell proliferation defined by
4i = [pFp(X;)- d]Bi. (31)
Different kinds of B cells, Bi, distinguished by the affinities
of their antibody receptors for the antigen, are assumed to
die at a constant rate d and to proliferate at maximum rate
p modulated by the fraction of receptor sites in cross-links,
Xi. For the dose-response function, Fp, we employ a Hill
function, Eq. 30, with proliferation threshold, Op. We take
the ligand site concentration to be an externally controlled
parameter, and thus, the concentration of cross-links is also
controlled externally. Clearly, a certain minimum number of
cross-links is required to induce enough proliferation to
overcome cell decay. The dotted line in Fig. 3 shows an
example of the ratio dip. All antigen concentrations, L, for
which the proliferation function, Fp, is larger than the dotted
line induce a net growth of the B cell clone characterized by
Fp. This is the stimulatory range of antigen concentration.
We call a cell Bi responsive when an antigen concentration
exists such that its proliferation rate exceeds its death rate.
Besides the parameters Op and q characterizing the response
function, the responsiveness of a cell depends on the affinity
of its antibody receptor for antigen. Not all B cells are
responsive to a given antigen.
A cell is capable of responding in the sense defined above
only if its proliferation at the optimally stimulatory ligand
site concentration, i.e., at the maximum of the cross-linking
curve, exceeds the decay rate. In the case of the binding of
a single type of bivalent ligand to cell receptors, the situa-
tion in an immune response against an antigen, the height of
the cross-linking curve is determined by RTKX only (cf. Eq.
29; when we consider the binding of a single type of ligand,
the averages in Eq. 29 reduce to the corresponding value for
the single ligand-receptor interaction):
2
Xmax = 1 + R- (1- lf+R~TK).RTKx (32)
The cell population can expand, if the maximum possible
proliferation overcompensates the death rate, i.e.,
pFp(Xmax) > d (33)
4(p/d - 1)"Vp 4ip
<* Kx>Kx,niin = R4(p/d - )Iq - g2 RT(pld -1
The critical cross-linking affinity, Kx,min, increases linearly
with the signaling threshold up unless p - (pld - 1)"q, in
which case the approximation in Eq. 33 does not hold.
B cell clones that have a cross-linking affinity slightly
larger than Kx,min will expand for a small range of antigen
concentrations centered at the optimal antigen concentra-
tion, Lr,max, which yields maximum cross-linking. The
larger RTKX the wider the range of antigen concentrations
for which the B cell clone grows. However, if the cross-
linking affinity is smaller than Kx,min the clone will not grow
at any concentration of the antigen. Thus, in a strict, math-
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ematical sense, the responsiveness of a B cell hinges on its
cross-linking affinity. The binding affinity determines only
the location of the maximum of the cross-linking curve, i.e.,
where the range of stimulatory antigen concentrations is
located. However, as a practical matter, cross-linking affin-
ity and binding affinity may be related (see below). And
even if KX > KXmin, the antigen concentration required to
stimulate a cell with a low binding affinity may be higher
than achievable under physiological conditions. In this
sense, the binding affinity also plays a role in determining
the observed responsiveness of cells.
The cross-linking affinity, which, according to Eq. 33,
determines the responsiveness of a given cell type, is diffi-
cult to measure (Erickson et al., 1991) and therefore is
generally not available. Instead, ligand-receptor interactions
are usually characterized by the binding affinity, which, by
itself, has only little influence on responsiveness. It is there-
fore desirable to establish a relationship between cross-
linking and binding affinities that would allow us to then
link a cell's responsiveness to its binding affinity for the
ligand. In fact, we expect cross-linking and binding affini-
ties to be related, because both are in part determined by
local interactions (van der Waals forces, etc.) between the
contact sites on the receptor and ligand. These local inter-
actions should remain roughly the same irrespective of
whether the ligand is in solution or already bound to the cell
at one site. This issue has previously been discussed from a
statistical mechanical perspective (Dembo and Goldstein,
1978; Dwyer and Bloomfield, 1981).
We expect that as the binding affinity of ligands in-
creases, their cross-linking affinity will also increase.
Goldstein and Wofsy (1994) argue that the difference be-
tween binding from solution and cross-linking on the cell
surface basically is that the bound ligand sees an effective
concentration of receptor sites such that
RTKX = CeK, (34)
where the effective receptor site concentration Ce depends
upon the geometry and flexibility of the receptor and ligand,
and the spatial distribution of receptors, but is independent
of the chemistry between ligand and receptors. Equation 34
implies a proportionality between binding and cross-linking
affinities. If this is the case, then the existence of a mini-
mum cross-linking affinity implies that there is also a min-
imum binding affinity for the B cell response. Experiments
by Klinman (1972), Teale and Klinman (1980), Riley and
Klinman (1986), and Mongini et al. (1991) support the idea
of a threshold affinity for triggering B cell events.
receptor interactions, with binding and cross-linking affin-
ities (Ki, KX j) and (Kj, Kj), respectively. Denote the ratio of
binding affinities by
(35)
Ki
Kij :---j
and the ratio of cross-linking affinities by
- KK,sj
This parameterization has the advantage that the case of
constant cross-linking affinity can be characterized indepen-
dently of the difference in affinity: 1ij = 0 means that the
two cross-linking affinities are identical. Likewise, propor-
tionality of binding and cross-linking affinity corresponds to
mij = 1 (again irrespective of the value of kj). Note, how-
ever, that this parameterization can describe any relation
between cross-linking affinities only if Ki 0 Kj. Therefore,
we exclude the case Ki = Kj from the following arguments
and comment on it at the end of the next section.
The parameter mij conveniently describes how changes in
cross-linking affinity are related to changes in binding af-
finity. The cross-linking affinity increases linearly with the
binding affinity, when qij = 1. It increases sublinearly when
mij < 1 and superlinearly when qij > 1, and is constant
when qij = 0. We allow also for cases with qij < 0, which
implies that an increase in binding affinity is accompanied
by a decrease in cross-linking affinity. Notice that the case
of almost identical effective concentrations of receptor sites
Ce implies mij 1.
It is easy to compare the cross-linking curves of ligand-
receptor interactions with identical qij = q (for all i and j).
Restricting our attention to this subset of all possible inter-
actions among a given collection of ligands and receptors, it
makes sense to talk about the affinity of an antibody-antigen
interaction, because once we specify one affinity character-
izing the interaction (e.g., K) the other affinity (e.g., Kx) is
determined. All of the next section will be concerned with
subsets of interactions that are homogeneous with respect to
,q. Different subsets of ligand and receptors, of course, can
behave differently, depending on the appropriate value of Ti.
The choice qij = q = 0 for the whole set of interactions
deserves special mention, because in this case we recover
the description of the B cell response previously used in
models of the idiotypic network (De Boer, 1988; Varela and
Stewart, 1990; Weisbuch et al., 1990). This special case is
studied by De Boer et al. (1996).
(36)
PARAMETERIZING THE MUTUAL DEPENDENCE
OF BINDING AND CROSS-LINKING AFFINITIES
We introduce a parameterization for the relationship be-
tween binding and cross-linking affinities that will facilitate
our ensuing analysis of the dependence of cross-linking
curves upon the two types of affinities. Consider two ligand-
RESPONSE CURVES OF CELLS WITH
DIFFERENT AFFINITY
During an immune response a variety of clones with
different affinities for the antigen become activated and
grow. In fact, the spectrum of affinities of the responsive
clones may change during the course of the response. In
studies examining the response to 2,4-dinitrophenyl
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FIGURE 4 Proliferation functions for different values of q. In each panel the proliferation function Fp is plotted for four different binding affinities:
K = 107, 106, 105, and 104 M-l (left to right). The parameters of Fp are 1p = 0.01 and q = 1. The horizontal line denotes dlp = 0.2. (Left) 7q = 0. With
-q = 0, the cross-linking affinity is independent of the binding affinity and hence is the same for each interaction. Here RTKX = 0.1 for all four curves. The
stimulatory range keeps its width and is shifted to the right for interactions of lower binding affinity. Low-affinity clones are stimulated better than
high-affinity clones at high ligand site concentration. (Middle) vj = 0.5. Here RTKX = 1.0, 0.1 \/T1, 0.1, and 0.01 /T15 (left to right). The width of the
stimulatory range decreases with decreasing affinity. Still, low-affinity clones receive better stimulation at high ligand site concentration. (Right) q = 1.
Here RTKX = 10, 1.0, 0.1, and 0.01 (left to right). The proliferation function of a low-affinity clone is embedded entirely within the proliferation function
of the clones with higher affinity. Clones with high affinity are always stimulated more than those with low affinity.
(DNP) attached to a protein carrier, it was found that
early in an immune response antibodies that bound DNP
have relatively low binding affinity (105 to 106 M-'),
whereas later in the response antibodies with high bind-
ing affinity (107 to 108 M-1) become prevalent (Eisen
and Siskind, 1964). Here we shall not discuss how this
increase in affinities for the antigen comes about. How-
ever, we explore the circumstances under which B cells
with high binding affinity receive better stimulation than
B cells with low binding affinity.
B cells carrying high-affinity immunoglobulin receptors
are stimulated better than those carrying low-affinity recep-
tors (irrespective of the ligand site concentration) when the
cross-linking curve for any antibody-antigen interaction
with given affinity is entirely embedded within the cross-
linking curve for every interaction with higher affinity.
Whether low-affinity cross-linking curves are actually em-
bedded in high-affinity cross-linking curves depends cru-
cially on how changes in binding affinity are related to
changes in cross-linking affinity.
Fig. 4 shows how proliferation functions change as the
affinities change, assuming homogeneous subsets of in-
teractions with different relationships between binding
and cross-linking affinities. We consider three cases: qr =
0, q = 0.5, and q = 1. If the cross-linking affinity is the
same for all antibody-antigen interactions ('r = 0), the
stimulatory range has identical width for all clones irre-
spective of the corresponding binding affinity. The cross-
linking curves and proliferation functions are simply
shifted to the right with decreasing affinity. Lower bind-
ing affinity can always be compensated by higher ligand
site concentration. For any given antigen concentration, a
particular clone is stimulated best. Clones with lower as
well as higher affinity receive less stimulation, and the
reduction in stimulation increases with the distance from
the optimally stimulated clone. Because with q = 0 the
height of the cross-linking curve remains the same for
different values of the binding affinity, either all clones
or no clones respond to antigen, i.e., have a maximum
proliferation rate that is greater than their death rate.
However, if cells respond then the ligand concentration
will be important in determining the degree of response.
If the cross-linking affinity increases sublinearly with the
binding affinity (71 = 0.5), the stimulatory range increases
in width with increasing affinities. At high ligand site con-
centration low-affinity clones can still be stimulated better
than high-affinity clones. However, the range of antigen
concentrations where this happens is considerably narrower
than in the case r = 0.
If the cross-linking affinity increases linearly (or super-
linearly) with the binding affinity (rg ' 1), low-affinity
clones are stimulated less than high-affinity clones, irre-
spective of the antigen concentration. The proliferation
function of a clone of any affinity is nested within the
proliferation functions of clones having higher affinity for
the antigen. We conclude this section by formally proving
this fact.
For the following arguments we choose the binding af-
finity, K, and the cross-linking affinity, Kx, of an arbitrary,
but fixed, ligand-receptor interaction in the subset of ligand-
receptor pairs being studied as a point of reference and
measure all binding and cross-linking affinities with respect
to K and Kx, respectively. Then any ligand-receptor inter-
action can then be characterized by
Kj= KjK and KX,i= OK.. (37)
To determine whether response functions for interactions of
different affinities intersect, we consider the derivative of
the response function Fr (or in the case of proliferation Fp)
with respect to Ki for the response to a single ligand at total
ligand site concentration Lr. A given response function is
completely embedded within those for interactions with
higher affinities when this derivative is positive irrespective
of the ligand site concentration. Under these conditions, an
increase in affinity will lead to higher response at all ligand
site concentrations.
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Because of the monotonic dependence of the response
function Fr on the concentration of cross-links X, and of X
upon 8 (cf. Eq. 23), it suffices to consider the derivative of
8 as a function of Ki. Dropping the subscript i for conve-
nience, from Eqs. 18, 19, 21, and 37,
K1 +"RTKXKLT
5(K) = (1 + KKLr)2' (38)
and hence
as KnRTKxKLr
dK (1+K )3 [(71 + 1) + ( I- )KKLT]. (39)
For :q 1, the derivative aS/aK is strictly positive for all
values of LT. Thus an increase in affinity will lead to a
higher 8 and hence a higher response at all ligand site
concentrations. This shows that the response functions are
nested within one another.
We can obtain further useful information from Eq. 39.
When i1 < 1, there exist values of LT for which aW/aK > 0
is no longer true and thus the response curves will cross.
This is seen in Fig. 4. For
-q = 1,
as 2KRTKXKL'
aK (1 + KKLT)3, (40)
which approaches 0 for LT -°oo. Thus, as indicated in Fig.
4, the response curves will converge at high ligand site
concentrations.
In summary, cross-linking curves are embedded within
one another when cross-linking affinities increase at least as
fast as the corresponding binding affinities, i.e., -q . 1.
Under these conditions a high-affinity clone is always stim-
ulated more than a low-affinity clone. If cross-linking af-
finities increase sublinearly with the binding affinities, there
is a range of ligand site concentrations where low-affinity
clones are stimulated more than high-affinity clones. Let us
compare the response of two clones, clones 1 and 2, having
high and low affinity for an antigen, respectively. We
choose to measure affinities with respect to (KI, Kx,1),
which implies KI = 1 and K2 < 1. The low-affinity clone 2
is stimulated more than the high-affinity clone 1 when
Ma/aK < 0, i.e., for
1+-i 1
1 K2K K' (41)
when 0 < K< 1. This range is located at ligand site
concentrations larger than the optimally stimulatory one
(K-1 = K1 1) for the high-affinity clone.
Finally, if for a subset of interactions the binding affini-
ties are the same but the cross-linking affinities are differ-
ent, cross-linking curves of interactions with low cross-
linking affinity are embedded within those of interactions
with higher cross-linking affinity. The cross-linking affinity
only modulates the height of the cross-linking curve but
leaves the location of the maximum unchanged.
The graphs shown in the right panel of Fig. 4 bear a
striking resemblance to curves published by Dembo and
Goldstein (1978) for the inhibition of cross-linking by
monovalent hapten. This turns out not to be an accident but
a result of the mathematics of cross-linking. Cross-linking
curves at different hapten concentrations HT are nested
within each other exactly like the cross-linking curves for
different affinities when the cross-linking affinity increases
linearly with the binding affinity. This equivalence is easy
to understand. In the presence of monovalent hapten at
concentration HT binding with affinity Kh to the same
receptor as the ligand LT, the concentration of cross-links X
is determined by Eq. 22 with 8 now modified to take into
account hapten binding. According to Dembo and Goldstein
(1978),
RTKxKLr RTK'XK'Lr
8=(- _(I + KLr + KhHT)2 (I + K LT)2) (42)
where K' = K/(1 + KhHT) and K'X = KI/(l + KhHT). Thus,
both the binding and the cross-linking affinity of the biva-
lent ligand are reduced by a factor 1/(1 + KhHT). Hence, the
effective binding and cross-linking affinities decrease pro-
portionally to each other as the hapten concentration in-
creases. In other words, the effective cross-linking affinity
changes linearly with the effective binding affinity. The
case of a linear change of a true cross-linking affinity as
function of the true binding affinity is thus formally equiv-
alent to the change of cross-linking curves by inhibitory
monovalent hapten.
EFFICIENCY OF MONOCLONAL AND
POLYCLONAL STIMULI
Frequently, antibodies against cell surface markers and re-
ceptors are used to stimulate, tolerize, or even kill cells in
the immune system (e.g., Braun and Unanue, 1980; Jonsson
and Eichmann, 1990; Gascan et al., 1991; Finkelman et al.,
1995; Morel et al., 1992; Shizuru et al., 1992). Polyclonal
antibody sera frequently prove to be more potent immune
modulators than monoclonal antibodies (J. Uhr, personal
communication). One possible explanation for this differ-
ence, in systems that respond to cross-linking, is that rare
high-affinity antibodies present in the polyclonal serum at
low concentrations may be disproportionately effective at
cross-linking receptors. We show this by the following
example.
For illustrative purposes, consider the simple polyclonal
serum composed of a collection of three different antibodies
(70% low-affinity (105 M-1), 23% medium-affinity (106
M-1), and 7% high-affinity (107 M-')) that we have intro-
duced in the first section. Assume
-q = 1, so that the
cross-linking constants for these three antibodies also vary
by factors of 10 (serum P1 in Fig. 1). This serum has an
average binding affinity of (K) = 106 M-' and an average
nondimensional cross-linking affinity of RT(KX) = 1. In Fig.
5 we compare cross-linking induced by the serum P1 with
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FIGURE 5 Cross-linking induced by polyclonal versus monoclonal sera. (a) compares the crosslinking curve for polyclonal (solid) and for monoclonal
(dashed) sera, both of which have the save average binding affinity (106 M-'). We observe that the polyclonal serum yields about three times as many
cross-links as the monoclonal antibody over the entire range of ligand concentrations. For the polyclonal serum, (b) shows the percentages of antibodies
of different affinities in the total antibody population (light gray bars) and in the population of antibodies forming cross-links (dark gray bars). The
high-affinity antibodies are drastically enriched in cross-links. Binding affinities are paired with cross-linking affinities such that (K, RTKX) = (105, 0.1),
(106, 1), and (107, 10), i.e., q = 1.
that induced by a monoclonal antibody with the average
binding affinity and the average cross-linking affinity of the
serum. As illustrated in Fig. 5 a, the polyclonal serum
induces about three times as many cross-links as the mono-
clonal antibody. If cell response is proportional to the de-
gree of receptor cross-linking, the polyclonal serum will be
a more potent stimulator of the cellular response than the
equivalent monoclonal antibody.
Receptors that require cross-linking to induce a signal are
very efficient in selecting the high-affinity fraction of ligand
collections. Fig. 5 b shows that in this example more than
96% of the cross-links are formed by the high-affinity
antibodies, although they constitute only 7% of the total
antibody concentration in the polyclonal serum. Conversely,
the low-affinity antibodies, which at 70% represent the
majority of the total antibody population, can be found in
less than 0.1% of the cross-links. The fact that cross-linking
involves two sequential binding events implies that im-
provements in affinity are sensed twice by the receptor. The
ratio of cross-links formed by antibody k and antibody e,
with cross-linking and binding affinities Kx k,Kk and
Kx,e,Ke, respectively, is (cf. Eqs. 11 and 12)
Xk Kx,kKk4T (43)
Xe KxeKeL&(43)
Thus, the partial concentration of cross-links formed by a
particular ligand increases linearly with the product of bind-
ing and cross-linking affinity. The same effect is not seen
with regard to singly bound antibodies because the corre-
sponding ratio of singly bound antibodies of different types
is
Sk KkLkT
Se KeLe(4
If q = 1, the case considered in Fig. 5, then a 10-fold
difference in binding affinity between the two antibodies,
e.g., Kk = IOKe, implies
Xk 1OOLkt Sk lOLkT
Xe L, and S- LeT (45)
Our prediction can be verified by mixing three monoclonal
antibodies binding to the same site on the receptor such that
the average binding affinity of the mixture is identical to the
binding affinity of the medium-affinity antibody. Assuming
that the affinities are ordered such that K1 < K2 < K3, then
the composition of the mixture must satisfy
I-f2 K3-K1
f3 K2-K1'
fi = 1 - f2 -f3,
(46)
(47)
with 0 < fi < 1, for the average binding affinity of the
mixture to be identical to K2. Our theory predicts that if
> 0 the mixture will be more effective than the mono-
clonal antibody of average affinity.
This example is a fairly crude caricature of polyclonal
sera in that it contains only three antibodies with affinities
differing by a factor of 10. We obtain the same qualitative
results for large collections of antibodies with an almost
continuous distribution of affinities (unpublished results).
CONCLUSIONS
We have modeled the cross-linking of cell surface receptors
by a set of bivalent ligands having different affinities for the
receptor such as might be found in a polyclonal anti-recep-
tor serum. We have assumed that the equilibrium concen-
tration of receptor cross-links on the cell surface determines
(b)
1o/
1164 Biophysical Joumal
Binding and Cross-Linking by Bivalent Ligands
the extent of ensuing cellular responses such as proliferation
or differentiation. Then, the concentration of cross-links
expressed as a function of the ligand site concentration, i.e.,
the cross-linking curve, and the dose-response relationship
of a cell are closely related to each other.
On a logarithmic scale the cross-linking curve is a bell-
shaped function of the total ligand site concentration under
the condition that the relative concentrations of all ligands
are constant, i.e., the ligand composition is fixed. Thus, the
bell-shaped form of the cross-linking curve, which has been
previously established for the case of the binding of a single
bivalent ligand (Dembo and Goldstein, 1978; Perelson and
DeLisi, 1980), is preserved in the case of a set of many
different ligands.
Binding and cross-linking affinity
A complete description of the cross-linking curve requires
the definition of two quantities that both depend upon the
concentration of each ligand individually. The first, the
binding field, is the sum of all ligand site concentrations
weighted by their respective binding affinities. (We call the
equilibrium constant for the binding of a ligand from solu-
tion to a site of a cell-surface receptor the binding affinity
(this is conventionally called the affinity of ligand for the
receptor) and the equilibrium constant for the binding to a
receptor site of the second site on a ligand already bound at
one site the cross-linking affinity, because the latter process
cross-links receptors.) The second, the cross-linkingfield, is
the sum of all ligand site concentrations weighted by the
product of their respective binding and cross-linking affin-
ities and multiplied by the receptor site density. Both fields
are necessary to capture the essential features of the cross-
linking curve. In general, neither field can be reduced to a
function of the other. For a fixed ligand composition (see
Excess Ligand Regime, above, for the definition), the bind-
ing field determines the location of the maximum of the
cross-linking curve whereas the cross-linking field affects
the curve's width and height. Both the width and height of
the cross-linking curve increase as the cross-linking field
increases.
Ligand-receptor interactions are usually characterized by
their binding affinity only, because the value of the cross-
linking affinity is difficult to measure (Erickson et al.,
1991). On the other hand, as we have just argued, knowl-
edge of the cross-linking affinity and receptor site density is
essential for predicting the concentration of cross-links. Can
we infer the value of the cross-linking affinity knowing the
value of the binding affinity? Goldstein and Wofsy (1994)
suggest that cross-linking affinity is proportional to binding
affinity. Generalizing this, we have suggested that for a
class of ligands and receptors, and in particular for a single
bivalent ligand binding to a set of receptors that have similar
physical structure, e.g., immunoglobulins of a given sub-
class, there may exist a linear relationship between binding
consider a variety of different relationships between binding
and cross-linking affinities.
How binding and cross-linking affinity depend upon each
other determines the mutual relationship of the different
cross-linking curves resulting from the binding of a pure
sample of a ligand to cells carrying different receptors.
Linear dependence separates two qualitatively different
kinds of relationship. When the cross-linking affinities in-
crease at least linearly with the binding affinities, the cross-
linking curve for any particular ligand-receptor interaction
is entirely nested within those of higher-affinity interactions
(Fig. 4, right). Here we assume a homogeneous relationship
between binding and cross-linking affinity, i.e., r1ij = q, for
all i and j. In this case, specifying one affinity for a ligand-
receptor interaction determines the value of the other affin-
ity (see Parameterizing the Mutual Dependence of Binding
and Cross-linking Affinities). Then talking about the affin-
ity of an interaction is meaningful. When, on the other hand,
the cross-linking affinities increase sublinearly with the
binding affinities, low-affinity interactions give rise to a
larger number of cross-links than high-affinity interactions
at high ligand site concentrations. This qualitative differ-
ence has important consequences for the behavior of idio-
typically interacting B cell clones (De Boer et al., 1996).
Is the equilibrium number of cross-links relevant
for the cellular response?
The theory presented here depends on two key assumptions:
1) the number of receptor sites on a cell surface is constant,
and 2) receptor-ligand binding and cross-linking come to
equilibrium rapidly compared with the time scale for a
cellular response. The receptors on a B cell are internalized
within an hour after the start of binding (Pure and Tardelli,
1992). Thus, for our theory to be valid equilibrium needs to
be reached on a time scale of less than an hour. The time
scale on which binding from solution relaxes to its equilib-
rium, assuming excess ligand, is 1 (k+ Lr + k-). If this time
is on the order of 103 s or greater our approach is no longer
valid.
Faro and Velasco (1993, 1994) developed a kinetic cri-
terion for B cell activation based on the idea that a very
large receptor cluster needs to be formed within some
critical time to activate the cell. Their model assumes that
the formation of cross-links is an irreversible process. For
binding and cross-linking reactions that are slow to equili-
brate, we agree with Faro and Velasco (1993, 1994) in that
a dynamical criterion is needed to describe the relationship
between receptor binding and cell activation. However, we
feel it would be desirable to develop dynamical criteria
using models with slow but reversible cross-linking. In this
case, Perelson (1980) shows that, as binding relaxes to its
equilibrium, the cross-linking curves are bell-shaped, attain
their maximum at lower ligand concentrations, and become
and cross-linking affinity. In general, however, one has to
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higher and wider as time progresses.
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Multivalent ligands
We have rigorously analyzed cross-linking curves and re-
sponse functions for the binding of bivalent ligand to re-
ceptor sites. We remark, however, that the qualitative fea-
tures of cross-linking curves for multivalent ligands are the
same as those of the cross-linking curves for bivalent li-
gands. In particular, the width and the height of cross-
linking curves increase with the cross-linking affinities, and
the position of its maximum moves to lower concentrations
(Perelson, 1981). Consequently, high-affinity interactions
are again favored compared with low-affinity interactions.
The range of stimulatory ligand site concentrations is larger
and the stimulation is higher anywhere provided the cross-
linking affinities grow at least linearly with the binding
affinities.
Describing the cross-linking curve for an n-valent ligand
accurately requires n fields. However, it is not possible to
obtain an explicit expression for the concentration of cross-
links when the valence of the ligand is larger than 4.
(Because the order of the polynomial describing the fraction
of free receptor sites (cf. Eq. 13) becomes larger than 4, one
can no longer obtain analytical solutions.) Qualitatively, the
main effect of increasing the valence is that the formation of
multiple cross-links on a single ligand allows for a larger
number of cross-links at low ligand site concentrations. The
number of cross-links hardly differs for ligands of different
valence at ligand site concentrations larger than the inverse
of the binding affinity-the location of the maximum of the
cross-linking curve of bivalent ligand. Consequently, cross-
linking curves become asymmetric around their maximum
and the asymmetry increases with valence and cross-linking
affinity (Perelson, 1981; Sulzer and Perelson, 1996).
Cellular response
Knowing just the number of cross-links on a cell does not
tell us whether the cell will become activated and perform
any kind of response. Here we have adopted the view that
the rate at which a cell responds increases strictly mono-
tonically with the equilibrium number of cross-links on the
cell. A phenomenological response function relates the
number of cross-links to the observed response rate. In
general, different types of response will be characterized by
different response functions. Moreover, responses typically
depend on signals other than cross-linking signals. Thus, in
T cell-dependent B cell responses, other cell surface recep-
tors need to be engaged to generate a response, and the
degree of their engagement may modulate the response to
cross-linking (cf. De Boer and Hogeweg, 1989; Carter and
Fearon, 1992; Neumann and Perelson, manuscript in prep-
aration). This means that responses may differ in their
requirement for cross-linking, a phenomenon seen in hista-
mine release from human basophils (cf. MacGlashan et al.,
1986; MacGlashan, 1983).
Being a function of the concentration of cross-links,
well as the cross-linking field. Phenomenological dose-
response functions frequently used in models of B cell
response (De Boer, 1988; Varela et al., 1988; Weisbuch
et al., 1990; De Boer et al., 1992; Sulzer et al., 1993) depend
only on one parameter, an analog of the binding field.
Because these functions depend only on a binding affinity-
like parameter they miss an important aspect of the under-
lying cross-linking function.
An improvement over one-parameter response functions
concerns the relative stimulation of clones with different
affinity for the antigen at the same antigen concentration.
When the cellular response is modeled by a one-parameter
function, low affinity can always be compensated for by a
large ligand concentration. However, when the cellular re-
sponse depends on both binding affinity and cross-linking
affinity this is no longer the case. As discussed under
Response Curves of Cells with Different Affinity, high-
affinity clones are stimulated more than low-affinity clones
at any antigen concentration provided the cross-linking af-
finities increase linearly or superlinearly with the corre-
sponding binding affinities. Even if the cross-linking affin-
ities grow sublinearly, the range of antigen concentrations
where the stimulus of low-affinity clones exceeds that of
high-affinity clones is much narrower than for one-param-
eter response functions. These results are consistent with in
vitro data of Rudich et al. (1988), which show that the
proliferation of human B cells increases as the affinity of the
stimulating monoclonal antibody increases.
We have examined the proliferative response of B cells
due to cross-linking of their membrane immunoglobulin
receptors under Cellular Response, above. Because B cells
are subjected to a natural decay process, cross-linking-
induced proliferation must overcompensate cell decay be-
fore a B cell clone can expand. A minimum cross-linking
affinity is required for sufficient cross-linking and, in turn,
for proliferation to outpace death. Assuming that binding
and cross-linking affinities are covariant, we conclude that
B cell clones having too low an affinity for the antigen do
not expand and are apparently nonresponsive. We consider
the lack of expansion of low-affinity clones at any antigen
concentration a very realistic feature of our phenomenolog-
ical model of the B cell response (Klinman, 1972; Teale and
Klinman, 1980; Riley and Klinman, 1986; Mongini et al.,
1991). This feature was absent from models where only the
binding field determined the dose dependence of the prolif-
eration rate.
Finally, we have proposed an explanation for the obser-
vation that polyclonal sera are frequently more effective
stimuli than monoclonal antibodies under circumstances
where signaling requires cross-linking. When exposed to a
polyclonal serum, cell-bound receptors preferably bind the
high-affinity component of the serum. Thus the cells pref-
erentially accumulate on their surface the high-affinity frac-
tions of the serum, provided both binding and cross-linking
affinity are large (cf. Fig. 1). These results show that com-
parison of the binding properties of receptor-ligand interac-
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dose-response relationships depend upon the binding as
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tions depends critically on both the binding affinity and the
cross-linking affinity.
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